Correlation Between Black Diamond and Radcom

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Black Diamond and Radcom at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Black Diamond and Radcom into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Black Diamond Therapeutics and Radcom, you can compare the effects of market volatilities on Black Diamond and Radcom and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Black Diamond with a short position of Radcom. Check out your portfolio center. Please also check ongoing floating volatility patterns of Black Diamond and Radcom.

Diversification Opportunities for Black Diamond and Radcom

-0.79
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Black and Radcom is -0.79. Overlapping area represents the amount of risk that can be diversified away by holding Black Diamond Therapeutics and Radcom in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Radcom and Black Diamond is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Black Diamond Therapeutics are associated (or correlated) with Radcom. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Radcom has no effect on the direction of Black Diamond i.e., Black Diamond and Radcom go up and down completely randomly.

Pair Corralation between Black Diamond and Radcom

Given the investment horizon of 90 days Black Diamond Therapeutics is expected to under-perform the Radcom. But the stock apears to be less risky and, when comparing its historical volatility, Black Diamond Therapeutics is 1.05 times less risky than Radcom. The stock trades about -0.26 of its potential returns per unit of risk. The Radcom is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  1,199  in Radcom on September 14, 2024 and sell it today you would lose (8.00) from holding Radcom or give up 0.67% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Black Diamond Therapeutics  vs.  Radcom

 Performance 
       Timeline  
Black Diamond Therap 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Black Diamond Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Radcom 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Radcom are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very fragile fundamental indicators, Radcom displayed solid returns over the last few months and may actually be approaching a breakup point.

Black Diamond and Radcom Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Black Diamond and Radcom

The main advantage of trading using opposite Black Diamond and Radcom positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Black Diamond position performs unexpectedly, Radcom can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Radcom will offset losses from the drop in Radcom's long position.
The idea behind Black Diamond Therapeutics and Radcom pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Bonds Directory
Find actively traded corporate debentures issued by US companies
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance